Search - tctmd.com

Displaying 361 - 380 of 406

Sort: Relevancy | Date

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Leah Lawrence

January 05, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

Advertisement

SCAAR: Second-Generation DES Improve Hard Outcomes

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

PRISM Individualized Informed Consent Improves PCI Choice, Experience

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

First DES for Above-the-Knee Vascular Disease on the Horizon

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Long-term Antiplatelet Therapy: All Risk, No Benefit

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Selective Use of DES Saves Millions of Dollars a Year

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content